Reply to rebuttal: Gene variants of the cytochrome P450 CYP2C9 affect oral anticoagulation with warfarin

Thrombosis and Haemostasis

Volumn 86, Issue 3, 2001, Pages 938-

  Margaglione, M ^a   Brancaccio, V ^a   Ciampa, A ^a   Di Minno, G ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CYTOCHROME P450; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; DRUG METABOLISM; DRUG SENSITIVITY; GENETIC ANALYSIS; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; LETTER; PLEIOTROPY; PREVALENCE; PRIORITY JOURNAL; THROMBOSIS;

EID: 0034852615     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616159     Document Type: Letter

References (0)